US vape companies braced for the worst after rule change on synthetic nicotine

The US vaping industry expects the decision to treat synthetic nicotine products the same as tobacco products to devastate parts of the industry that have come to rely on it, with some businesses forced to close and others having to hope for enforcement discretion.

Synthetic nicotine will be treated the same as tobacco-derived nicotine by the US Food and Drug Administration (FDA) after president Joe Biden signed a sweeping $1.5tn omnibus spending bill.

The bill’s passing has caused a lot of concern among small businesses, which will no longer be able to compete, being less diversified and less able to leverage economies of scale or access capital markets.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization